MYC and neuroblastoma: The proteomic profiles of MYCN-amplified neuroblastoma cells treated with 10058-F4 or with specific MYCN short-hairpin RNA (shRNA) show similar affected Gene Ontology pathways and processes, where about half of the downregulated genes were previously characterized as MYC target genes [64].